Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Richard C Zanetti"'
Autor:
Patrick T. Reeves, Philip L. Rogers, Sean J. Hipp, Richard C. Zanetti, Sofia Echelmeyer, Donald J. Rees, Dina S. Parekh
Publikováno v:
Pediatric bloodcancer. 69(12)
Publikováno v:
Journal of Pediatric Hematology/Oncology. 43:e1145-e1147
Hyperhemolysis is a life-threatening condition of exaggerated hemolysis of red blood cells which occurs in patients receiving chronic transfusion therapy. We present a 19-year-old male with the β-thalassemia major with an episode of hyperhemolysis.
Publikováno v:
Section on Uniformed Services Program.
Introduction: Hyperhemolysis is a life-threatening condition of exaggerated hemolysis of red blood cells which occurs in patients receiving chronic transfusion therapy. Results: We present a 19-year-old male with β-thalassemia major with an episode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::778db24de69982523f20795886b55603
https://doi.org/10.22541/au.160262393.32375827/v1
https://doi.org/10.22541/au.160262393.32375827/v1
Publikováno v:
Journal of Pediatric Hematology/Oncology.
Introduction: 6-Mercaptopurine (6-MP) is the most frequently used chemotherapy agent in the management of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LL). Skewed drug metabolism can decrease the effectiveness of 6-MP while also res
Autor:
Ashley B Anderson, Richard C Zanetti, Benjamin K. Potter, Anne B. Warwick, Amie B Park, Lauren M Vasta, Kangmin Zhu, Jie Lin, Craig D. Shriver
Publikováno v:
Journal of pediatric hematology/oncology. 43(6)
Background We sought to compare survival outcomes of sarcomas in the pediatric and adolescent/young adult populations with universal care access in the Military Health System (MHS) to those from the United States general population. Methods We compar
Publikováno v:
Journal of pediatric hematology/oncology. 43(7)
Skewed drug metabolism of 6-mercaptopurine (6-MP) can jeopardize antileukemic effects and result in toxicities during the treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma. Allopurinol can alter 6-MP metabolism to maximize therapeu
Autor:
Richard C. Zanetti, Abhik K. Biswas
Publikováno v:
Military Medicine. 178:e1045-e1047
We report a case of a 19-year-old woman with cystic fibrosis who presented with hemolytic anemia during a course of piperacillin/tazobactam. The patient was initially managed with the replacement of blood products; however, she continued to show sign